Plasma and colostrum concentrations of fentanyl in clinical practice: Intravenous versus epidural administration for labor analgesia
5 affiliations
- 1Department of Obstetrics and Gynecology Sørlandet Hospital Kristiansand Kristiansand Norway
- 2Department of Clinical Pharmacology St. Olav`s University Hospital Trondheim Norway
- 3Department of Clinical and Molecular Medicine Norwegian University of Science and Technology Trondheim Norway
- 4Oslo Centre of Biostatistics and Epidemiology, Research Support Services Oslo University Hospital Oslo Norway
- 5Institute of Clinical Medicine University of Oslo Oslo Norway
Abstract
Introduction: Pain relief during labor is essential. Systemic opioids for labor analgesia have been used for decades as a less invasive alternative to epidural analgesia (EA). Although their analgesic efficacy is generally considered inferior to EA, concerns regarding potential maternal and neonatal adverse effects have likely limited their wider adoption. Measurements of fentanyl concentration may provide an objective assessment of systemic exposure and potential transfer to the fetus and colostrum. The aim of the study was to compare fentanyl concentrations in maternal plasma, umbilical cord blood, and colostrum following intravenous (midwife‐administered) versus epidural administration for labor analgesia. We also included a group of women, who initially received intravenous fentanyl but were subsequently converted to EA due to insufficient pain relief.
Material and Methods: This prospective study included three groups: women who received fentanyl epidurally only (EA), intravenously only (IV), or intravenously followed by epidural administration (IV + EA). Samples of maternal plasma, arterial and venous umbilical cord plasma, and two colostrum samples were collected for analysis of fentanyl concentration.
Results: A total of 98 women were included: 34 in the EA group, 38 in the IV group and 26 in the IV + EA group. Fentanyl concentrations were significantly higher in the IV group compared to the EA group in maternal plasma (0.25 ng/mL vs. 0.11 ng/mL, p < 0.001) and umbilical vein plasma (0.084 ng/mL vs. 0.054 ng/mL, p < 0.001). However, within the first 24 h postpartum, no significant differences in fentanyl concentrations were observed in colostrum samples between the IV and EA groups (0.020 ng/mL vs. 0.021 ng/mL, p = 0.93). The estimated theoretical infant dose through breastfeeding in the total study population was very low (0.0079 μg). All measured fentanyl concentrations were low and were accompanied by normal early warning scores, with no requirement for naloxone administration or ventilator support in any group.
Conclusions: Intravenous fentanyl for labor analgesia was associated with low fentanyl concentrations in maternal plasma, umbilical cord plasma, and colostrum. These findings suggest that intravenous fentanyl may be considered as an additional analgesic option for laboring women.
Related
- Comparison of subcutaneous and intravenous administration of the monoclonal antibody CSX-1004 on fentanyl-induced respiratory depression in squirrel monkeys
- Intraoperative intravenous lidocaine for analgesia after oral cancer surgery with free perforator flap reconstruction: a randomised controlled trial
- Combined Pectoral Nerve Block and Intravenous Dexmedetomidine in Contemporary Multimodal Breast Cancer Analgesia: A Real-World Cohort Study
- Decreasing fentanyl concentrations in urinalysis results for methadone treatment admissions: Evidence of changing fentanyl exposure in street drugs.
- Postoperative Opioid-Free Multistep Opiranserin Infusion Versus Fentanyl Patient-Controlled Analgesia After Breast or Minimally Invasive Gynecologic Surgery: A Retrospective Cohort Study
BibTeX
@article{nygaard2026plasma,
title = {{Plasma and colostrum concentrations of fentanyl in clinical practice: Intravenous versus epidural administration for labor analgesia}},
author = {Benedicte Sandhaug Nygaard and Ragnhild Bergene Skråstad and Olav Spigset and Tonje Gottenberg Skaalvik and Are Hugo Pripp and Janne Rossen},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2026},
month = sep,
doi = {10.1111/aogs.70302},
url = {https://doi.org/10.1111/aogs.70302},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Plasma and colostrum concentrations of fentanyl in clinical practice: Intravenous versus epidural administration for labor analgesia
AU - Benedicte Sandhaug Nygaard
AU - Ragnhild Bergene Skråstad
AU - Olav Spigset
AU - Tonje Gottenberg Skaalvik
AU - Are Hugo Pripp
AU - Janne Rossen
PY - 2026
DA - 2026/09/11
JO - Acta Obstetricia et Gynecologica Scandinavica
DO - 10.1111/aogs.70302
UR - https://doi.org/10.1111/aogs.70302
AB - Introduction: Pain relief during labor is essential. Systemic opioids for labor analgesia have been used for decades as a less invasive alternative to epidural analgesia (EA). Although their analgesic efficacy is generally considered inferior to EA, concerns regarding potential maternal and neonatal adverse effects have likely limited their wider adoption. Measurements of fentanyl concentration may provide an objective assessment of systemic exposure and potential transfer to the fetus and colostrum. The aim of the study was to compare fentanyl concentrations in maternal plasma, umbilical cord blood, and colostrum following intravenous (midwife‐administered) versus epidural administration for labor analgesia. We also included a group of women, who initially received intravenous fentanyl but were subsequently converted to EA due to insufficient pain relief. Material and Methods: This prospective study included three groups: women who received fentanyl epidurally only (EA), intravenously only (IV), or intravenously followed by epidural administration (IV + EA). Samples of maternal plasma, arterial and venous umbilical cord plasma, and two colostrum samples were collected for analysis of fentanyl concentration. Results: A total of 98 women were included: 34 in the EA group, 38 in the IV group and 26 in the IV + EA group. Fentanyl concentrations were significantly higher in the IV group compared to the EA group in maternal plasma (0.25 ng/mL vs. 0.11 ng/mL, p < 0.001) and umbilical vein plasma (0.084 ng/mL vs. 0.054 ng/mL, p < 0.001). However, within the first 24 h postpartum, no significant differences in fentanyl concentrations were observed in colostrum samples between the IV and EA groups (0.020 ng/mL vs. 0.021 ng/mL, p = 0.93). The estimated theoretical infant dose through breastfeeding in the total study population was very low (0.0079 μg). All measured fentanyl concentrations were low and were accompanied by normal early warning scores, with no requirement for naloxone administration or ventilator support in any group. Conclusions: Intravenous fentanyl for labor analgesia was associated with low fentanyl concentrations in maternal plasma, umbilical cord plasma, and colostrum. These findings suggest that intravenous fentanyl may be considered as an additional analgesic option for laboring women.
SN - 0001-6349
SN - 1600-0412
ER -